Search results for "contrast material"

showing 2 items of 2 documents

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

2015

Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.

Gadolinium DTPALiver CirrhosisGadoxetic acidCirrhotic livermedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisCarcinoma HepatocellularGadoxetic acidContrast MediaGastroenterology030218 nuclear medicine & medical imagingResection03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patientTopic HighlightSettore MED/12 - GastroenterologiaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyHepatobiliary contrast materialMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSettore MED/18 - Chirurgia GeneraleLiver030220 oncology & carcinogenesisHepatobiliary phaseLiver functionSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging; Gastroenterologymedicine.drugWorld journal of gastroenterology
researchProduct

High Iodine Concentration Contrast Material for Noninvasive Multislice Computed Tomography Coronary Angiography

2006

OBJECTIVE: The objective of this study was to compare intracoronary attenuation on 16-row multislice computed tomography (16-MSCT) coronary angiography using 2 contrast materials (CM) with high iodine concentration. MATERIAL AND METHODS: Forty consecutive patients (29 male, 11 female; mean age, 61 ± 11 years) with suspected coronary artery disease were randomized to 2 groups to receive 100 mL of either iopromide 370 (group 1: Ultravist 370, 370 mg iodine/mL; Schering AG, Berlin, Germany) or iomeprol 400 (group 2: Iomeron 400, 400 mg iodine/mL; Bracco Imaging SpA, Milan, Italy). Both CM were administered at a rate of 4 mL/s. All patients underwent 16-MSCT coronary angiography (Sensation 16; …

AdultMaleCoronary angiographymedicine.medical_specialtyIohexolmedia_common.quotation_subjectContrast MediaCoronary Artery DiseasemedicineHumansContrast (vision)Radiology Nuclear Medicine and imagingHigh iodineAgedmedia_commonbusiness.industryIopromideMean ageGeneral MedicineMultislice computed tomographyMiddle AgedIopamidolcontrast materialIomeprol 400Injections IntravenousFemaleRadiologyTomographycoronary angiographyTomography X-Ray Computediodine concentrationbusiness16-row multislice CTmedicine.drugInvestigative Radiology
researchProduct